tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Kindstar Globalgene Completes Strategic Acquisitions and Expands Shareholder Base

Story Highlights
Kindstar Globalgene Completes Strategic Acquisitions and Expands Shareholder Base

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Kindstar Globalgene Technology, Inc. ( (HK:9960) ) just unveiled an announcement.

Kindstar Globalgene Technology, Inc. has completed the acquisition of equity interests in two target companies, enhancing its strategic positioning and expanding its operational capabilities. The completion of these acquisitions involves the issuance of shares to Wuxi Anchor and OrbiMed, reflecting the company’s commitment to growth and increased stakeholder value.

More about Kindstar Globalgene Technology, Inc.

Kindstar Globalgene Technology, Inc. operates in the biotechnology industry and is incorporated in the Cayman Islands. The company focuses on acquiring equity interests in other companies, aiming to consolidate its market position and expand its operations across different regions.

YTD Price Performance: -5.93%

Average Trading Volume: 571,423

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$1.09B

Learn more about 9960 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1